WASHINGTON, Sept. 10, 2025 /CNW/ -- Cloud Capital, a leading global data center investment management firm, today announced the final close of Cloud Capital Fund II, an opportunistic closed-end ...
Investing.com - Raymond James has reiterated an Outperform rating and $29.00 price target on Regenxbio Inc. (NASDAQ:RGNX) following the company’s update on its RGX-121 gene therapy program. The stock, ...
Thank you for standing by, and welcome to the Upstream Bio Phase II VIBRANT Top-line Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I would now like to ...
JCR Pharmaceuticals Presents Long-Term Clinical Data on Pabinafusp Alfa for the Treatment of Mucopolysaccharidosis Type II (MPS II) at ICIEM 2025 – Oral Presentation Highlights Long-Term ...
Cloud Capital has completed the final close of Fund II, a data center investment vehicle. The September 10 announcement revealed that the fund, which will focus on acquiring and developing hyperscale ...
Akeso Inc. announced that data from a phase Ib/II clinical study evaluating the combination of cadonilimab and pulocimab (an anti-VEGFR-2 antibody) in patients with immunotherapy (IO)-resistant NSCLC ...
Hello, everyone, and welcome to this investor call to discuss oveporexton Phase III data and commercial readiness. My name is Christopher O'Reilly, Head of Investor Relations at Takeda. Today's ...
Epstein files: Senate Republicans narrowly blocked an unexpected effort on Wednesday by Senator Chuck Schumer of New York, the Democratic leader, to force a vote on releasing the Epstein files and put ...
Certain styles of photography or videography immediately evoke an era. Black-and-white movies of flappers in bob cuts put us right in the roaring 20s, while a soft-focused, pastel heavy image with men ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback